![Alexandra MacLean](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/05/2026
Dr. Alexandra MacLean is a Chief Executive Officer & Director at Avenue Therapeutics, Inc. She is on the Board of Directors at Avenue Therapeutics, Inc. and Access Vascular, Inc. Dr. MacLean was previously employed as an Entrepreneur in Residence by Fortress Biotech, Inc., a Partner by TVM Capital GmbH, and a Head-Licensing & Business Development by Imbrium Therapeutics LP.
She received her undergraduate degree from McGill University, a graduate degree from the University of Cambridge, an MBA from the University of Colorado Boulder and a doctorate degree from Vagelos College of Physicians & Surgeons.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 25/11/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| AVENUE THERAPEUTICS, INC. | Director Ejecutivo | 01/08/2022 |
Access Vascular, Inc.
 Access Vascular, Inc. Medical SpecialtiesHealth Technology Access Vascular, Inc. engages in the development and manufacture of medical devices. It provides hydrogel-based medical devices, such as catheter and stenst to improve venous access. The firm also improves peripherally inserted central catheter, hemodialysis, implantable ports, and drug delivery devices. The company was founded by James Biggins in 2015 and is headquartered in Bedford, MA. | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| FORTRESS BIOTECH, INC. | Corporate Officer/Principal | 01/07/2022 |
TVM Capital GmbH
 TVM Capital GmbH Investment ManagersFinance TVM Capital invests in companies located in the United States and Europe. The firm focuses on information technology, communications and life sciences sectors. It provides financing for early and later stage capital requirements. It also acts as lead or co-lead investor. | Inversor de Capital Privado | 30/10/2021 |
Imbrium Therapeutics LP
 Imbrium Therapeutics LP Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Corporate Officer/Principal | 01/01/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Fortress Biotech, Inc.
 Fortress Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and biotechnology products | Health Technology |
TVM Capital GmbH
TVM Capital GmbH Investment ManagersFinance TVM Capital invests in companies located in the United States and Europe. The firm focuses on information technology, communications and life sciences sectors. It provides financing for early and later stage capital requirements. It also acts as lead or co-lead investor. | Finance |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Colorado Boulder
 University of Colorado Boulder Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avenue Therapeutics, Inc.
 Avenue Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops and commercializes therapies for neurological diseases | Health Technology |
Access Vascular, Inc.
Access Vascular, Inc. Medical SpecialtiesHealth Technology Access Vascular, Inc. engages in the development and manufacture of medical devices. It provides hydrogel-based medical devices, such as catheter and stenst to improve venous access. The firm also improves peripherally inserted central catheter, hemodialysis, implantable ports, and drug delivery devices. The company was founded by James Biggins in 2015 and is headquartered in Bedford, MA. | Health Technology |
Imbrium Therapeutics LP
Imbrium Therapeutics LP Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Health Technology |
Vagelos College of Physicians & Surgeons
 Vagelos College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
